Genmab
GMAB
#750
Rank
A$46.86 B
Marketcap
A$76.01
Share price
-1.32%
Change (1 day)
61.37%
Change (1 year)

EPS for Genmab (GMAB)

EPS in 2026 (TTM): A$2.62

According to Genmab's latest financial reports the company's current EPS (TTM) is A$2.68. In 2025 the company made an earnings per share (EPS) of A$2.33 a decrease over its 2024 EPS that were of A$2.56.

EPS history for Genmab from 2002 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$2.6212.86%
2025A$2.33-9.09%
2024A$2.5676.32%
2023A$1.45-20.44%
2022A$1.8273.57%
2021A$1.05-41.96%
2020A$1.81133.96%
2019A$0.7740.1%
2018A$0.5525.93%
2017A$0.444.18%
2016A$0.4246.79%
2015A$0.29118.84%
2014A$0.13114.51%
2013A$0.06108-121.72%
2012A-$0.28-19.1%
2011A-$0.3581.46%
2010A-$0.19-70.53%
2009A-$0.657.24%
2008A-$0.61137.03%
2007A-$0.26-14.43%
2006A-$0.30-0.22%
2005A-$0.30-30.15%
2004A-$0.4317.97%
2003A-$0.36-20.22%
2002A-$0.46